Mersana Therapeutics
Why Robinhood?
You can watch MRSN and buy or sell other stocks, ETFs, and their options commission-free!About MRSN
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.
MRSN Key Statistics
Stock Snapshot
With a market cap of 4.07B, Mersana Therapeutics(MRSN) trades at $29.08. The stock has a price-to-earnings ratio of -12.83.
On 2026-03-31, Mersana Therapeutics(MRSN) stock opened at —, reached a high of —, and a low of —.
Mersana Therapeutics(MRSN) shares are trading with a volume of 0, against a daily average of 2.98M.
During the past year, Mersana Therapeutics(MRSN) stock moved between $0.26 at its lowest and $2.83 at its peak.
During the past year, Mersana Therapeutics(MRSN) stock moved between $0.26 at its lowest and $2.83 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.